Nutriband inc. reports revenue up 113% yoy in q2

Orlando, fl / accesswire / september 8, 2022 / nutriband inc. (nasdaq:ntrb), a developer of transdermal pharmaceutical products, today announced financial and operational results for the second quarter ended july 31, 2022. key highlights: generated record quarterly revenue of $0.5 million, up 113% over q2 2021 revenue for six-months ended july 31, 2022 up 44% year-over-year received favorable final court judgment, related to a previously rescinded acquisition in 2017; the ruling enabled the company to cancel the 1.2 million shares ( 1.4m shares when adjusted for 7 for 6 forward split), representing 15% of nutriband's outstanding shares at the time, held by the defendants.
NTRB Ratings Summary
NTRB Quant Ranking